Diphenhydramine: Clinical Trials

207 trials of Diphenhydramine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

123 completed, 27 terminated, 17 recruiting, 15 active not recruiting. 77 Phase 2, 56 Phase 1, 34 Phase 3, 28 Phase 4, 27 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 277Completed 42, Terminated 15, Recruiting 10, Active not recruiting 5, Unknown 3, Not yet recruiting 2
Phase 156Completed 39, Terminated 8, Active not recruiting 4, Recruiting 3, Not yet recruiting 1, Unknown 1
Phase 334Completed 16, Active not recruiting 5, Recruiting 4, Unknown 4, Not yet recruiting 2, Terminated 2, Withdrawn 1
Phase 428Completed 22, Recruiting 3, Terminated 1, Unknown 1, Withdrawn 1
Not applicable27Completed 16, Unknown 4, Terminated 3, Active not recruiting 1, Recruiting 1, Suspended 1, Withdrawn 1
Early Phase 13Withdrawn 2, Completed 1

Follow Diphenhydramine: new trials by email Literature Review of Diphenhydramine trials Research Report on Diphenhydramine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer
Dexamethasone, Famotidine, Diphenhydramine - Triple Negative Breast Cancer, Triple Negative Breast Cancer (TNBC)
Phase 2Not yet recruitingWashington University School of Medicine172026-11-302026-11-03
A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001)
MK-6255, CD8 PET Tracer, Acetaminophen - Ovarian Neoplasms, Endometrial Neoplasms
Phase 1Not yet recruitingMerck Sharp & Dohme LLC802026-11-132026-11-16
Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project
Cetirizine, Diphenhydramine - Multiple Sclerosis
Phase 3Not yet recruitingUniversity of Miami602026-11-012026-10-02
A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
MK-1045, Acetaminophen (or similar antipyretic), Diphenhydramine (or similar antihistamine) - Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma
Phase 2RecruitingMerck Sharp & Dohme LLC602026-10-142026-11-13
Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer
Toripalimab (240mg day1, Q3W*3cycle), Diphenhydramine, Platinum-based chemotherapy - NSCLC
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital1202026-06-302026-06-12
Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions
Diphenhydramine, Placebo - Pain, Abortion
Phase 4RecruitingUniversity of Rochester982026-06-292026-08-21
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
MK-1045, Blinatumomab, Acetaminophen - B-cell Acute Lymphoblastic Leukemia
Phase 2 / Phase 3RecruitingMerck Sharp & Dohme LLC3402026-05-182026-11-10
A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
Sleep Hygiene Education, Melatonin IR, 3 mg, Melatonin IR, 5 mg - Insomnia, Insomnia Disorder
Phase 4RecruitingUniversity of Pennsylvania12002026-05-012026-09-16
Histamines and Central Hemodynamics
Diphenhydramine hydrochloride, Placebo, Exercise Bout - Histamine, Exercise
Not applicableRecruitingUniversity of British Columbia202025-12-012025-12-23
Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs
Lidocaine, Diphenhydramine - Laceration of Skin
Phase 3RecruitingFlorida Atlantic University1002025-09-032026-01-07
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion, 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion, 25 mg Diphenhydramine (5 min) + Normal Saline - Alcohol Use Disorder (AUD), Alcohol-Related Disorders
Phase 1RecruitingYale University632025-08-042026-09-10
Anticholinergics for Cervical Edema in Labor
Treatment with Diphenhydramine, Usual Care - Labor Dystocia
Phase 2 / Phase 3RecruitingThe University of Texas Health Science Center, Houston2002025-03-252026-05-06
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Isatuximab SC-OBDS, Montelukast, Dexamethasone - Plasma Cell Myeloma Refractory
Phase 2Active not recruitingSanofi642025-03-172026-10-26
Effects of Photobiomodulation (PBM) on Pain After Presentation of Aphthous Ulcers in Pediatric Dental Patients
PBM Therapy, Maalox plus Benadryl - Aphthous Ulcer
Phase 4RecruitingThe University of Texas Health Science Center, Houston302025-03-102025-03-25
Topical Tripelennamine 1% Cream Versus Diphenhydramine 1% Cream for the Relief of Histamine-Induced Itching: A Proof Concept Study in Healthy Adults.
Tripelennamine, Diphenhydramine, Vehicle Control Cream Base - Healthy
Early Phase 1CompletedPalm Beach Atlantic University372025-02-242026-08-21
Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis
Anti-itching and repairing treatment. Emollient., Emollient cream - Atopic Dermatitis, Eczema
Not applicableCompletedNAOS Les Laboratoires642024-12-092026-10-13
Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist(Diphenhydramine)in Advanced and Metastatic Non-Small Cell Lung Cancer
Diphenhydramine, Tislelizumab, Pemetrexed - Advanced and Metastatic NSCLC
Phase 3Not yet recruitingTianjin Medical University Cancer Institute and Hospital4302024-12-012024-12-16
Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria
Cetirizine Hydrochloride Injection, Diphenhydramine Hydrochloride Injection - Acute Urticaria
Phase 3RecruitingShandong New Time Pharmaceutical Co., LTD2842024-04-222025-02-11
Diphenhydramine in Catheter Related Bladder Discomfort
DiphenhydrAMINE 50 Mg/mL Injectable Solution, Saline - Catheter Complications
Not applicableUnknownCairo University1042024-04-012024-04-03
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
Iberdomide, Carfilzomib, Daratumumab - Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Phase 2RecruitingBenjamin T Diamond, MD302024-02-202026-03-11

Showing 20 of 207. Sign in to see all of them.

Conditions studied

Migraine Disorders (11)  ·  Multiple Myeloma (10)  ·  Pain (8)  ·  Headache (7)  ·  Lymphoma, Non-Hodgkin (7)  ·  Nausea (6)  ·  Neoplasms (6)  ·  Breast Neoplasms (5)  ·  Burkitt Lymphoma (5)  ·  Lymphoma (5)  ·  Vomiting (5)  ·  Hematologic Neoplasms (4)  ·  Hodgkin Disease (4)  ·  Leukemia (4)  ·  Lupus Erythematosus, Systemic (4)

Sponsors

National Cancer Institute (NCI) (17)  ·  M.D. Anderson Cancer Center (9)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (9)  ·  Sanofi (9)  ·  Hoffmann-La Roche (7)  ·  Montefiore Medical Center (7)  ·  Genentech, Inc. (5)  ·  Stanford University (5)  ·  Merck Sharp & Dohme LLC (4)  ·  Arrowhead Pharmaceuticals (3)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (3)  ·  Bayer (2)  ·  Charleston Laboratories, Inc (2)  ·  Dr. Reddy's Laboratories Limited (2)  ·  Eli Lilly and Company (2)

Countries

United States (156)  ·  Canada (18)  ·  Spain (14)  ·  China (11)  ·  France (11)  ·  Italy (11)  ·  Brazil (9)  ·  Germany (9)  ·  Poland (9)  ·  United Kingdom (8)  ·  Australia (7)  ·  Japan (7)  ·  Israel (6)  ·  Greece (5)  ·  Russia (5)

Top investigators

Alice P Chen, M.D. (2)  ·  Janine North, B.S. (2)  ·  Jeffrey Bluestone, PhD (2)  ·  Melissa Israel, BS (2)  ·  N. Netaji, MD (2)  ·  Paul Brunetta, M.D. (2)  ·  Qizhi Tang, PhD (2)

Results publications

PMID 37678236, PMID 33693991, PMID 35622074, PMID 10662747, PMID 11535479, PMID 11904109, PMID 11927799, PMID 12119802, PMID 12598264, PMID 12764341, PMID 12832331, PMID 14633551, PMID 15066944, PMID 15107371, PMID 15710782, PMID 15738343, PMID 15834219, PMID 16804691, PMID 17157685, PMID 17515447, PMID 17515448, PMID 17560739, PMID 18006188, PMID 18387702, PMID 18534808, PMID 18770076, PMID 18958996, PMID 19320625, PMID 20039413, PMID 20045576, PMID 20179242, PMID 20837887, PMID 21464363, PMID 21676165, PMID 21873334, PMID 21880111, PMID 22231479, PMID 22311903, PMID 22563089, PMID 23385150, PMID 23446076, PMID 23567060, PMID 23607840, PMID 23936605, PMID 24030379, PMID 24094754, PMID 24127709, PMID 24180163, PMID 24462034, PMID 24465046

NIH funding

2023 (9), 2019 (4), 2025 (2), 2008 (1), 2014 (1), 2015 (1), 2016 (1), K24DA023186 (1), P01CA049605 (1), P30CA033572 (1), P50HD109861 (1), R01AA013746 (1), R01AT005819 (1), R21AA030649 (1), R34AI095135 (1)